Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results

d Statements of Operations(In thousands, except per share data)(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2010200920102009Revenues:Product sales, net

29,080$  105,393$
73,309License revenue

-2,917-3,055Total revenues

42,02031,997105,39376,364Cost of products sold

9,6787,30425,17118,647Gross profit margin

32,34224,69380,22257,717Costs and expenses:Research and development

7,9456,25717,77919,643Selling, general and administrative

19,61413,18760,38338,874Total costs and expenses

27,55919,44478,16258,517Income (loss) from operations

4,7835,2492,060(800)Other (expense) income:Interest expense

(2,081)(2,779)(6,225)(6,494)Gain on derivative valuation

1173191301,158Gain (loss) on warrant valuation

(26,338)(3,396)7,159(50,703)Other, net

3(310)3(336)Total other (expense) income, net

(28,299)(6,166)1,067(56,375)Net (loss) income  

3,127$   (57,175)Net (loss) income per common share, basic

(1.72)Shares used in computing net (loss) income per common share, basic

33,48333,25133,41833,210Net (loss) income per common share, diluted

(1.72)Shares used in computing net (loss) income per common share, diluted

33,48333,25142,93933,210ISTA Pharmaceuticals, Inc.Summary of Balance Sheet Data(In thousands)(unaudited)September 30,December 31,20102009Cash

53,702Working capital

8,80829,113Total assets

112,17589,144Current portion of Facility Agreement

21,450-Facility Agreement, net of current portion

37,99457,438Total stockholders' deficit

(71,838)(78,028)Web Site:

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
2. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
3. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
6. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
7. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
10. VIDEO from and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
11. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Post Your Comments:
(Date:3/27/2015)... BROOKFIELD, Wis. , March 27, 2015 /PRNewswire/ ... 40,000 unit shipments of incontinence devices for women. ... terrific, but the most gratifying part is the ... receive from women whose lives have been positively ... , president of InControl. InControl recently ...
(Date:3/27/2015)... 27, 2015 adds ... market research report of 52 pages with latest ... intelligence library. The report "Visceral Pain - Pipeline ... therapeutic development for Visceral Pain, complete with comparative ... target, mechanism of action (MoA), route of administration ...
(Date:3/26/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... therapies for cardiovascular disease and overall health, announced that ... of the Corporation (the "Common Shares"). The Common Shares ... 5 th , 2014 to March 4 th , ... on or before April 1, 2015. Interest on the ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... Pa., Oct. 22 Cephalon, Inc. (Nasdaq: ... Strategies (REMS) for its medications NUVIGIL® (armodafinil) Tablets [C-IV] ... the U.S. Food and Drug Administration (FDA).  Both the ... to inform patients about the potential risks associated with ...
... China, Oct. 22 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation ... Medicine" or "the Company"), a leading manufacturer, developer ... ("TCM"), and other health products, today announced that ... financial results after market close on Wednesday, November ...
Cached Medicine Technology:Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL 2Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL 3Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL 4
(Date:3/28/2015)... Centurion Service Group will be hosting a live ... at their Las Vegas warehouse, located at 4606 Andrews St. ... consists of equipment from hospitals and surgery centers from around ... , Buyers will find items of all types including ... one-stop-shop,” said Erik Tivin, CEO of Centurion. , Among the ...
(Date:3/28/2015)... Early surgery may not be the ... joint injuries, according to new research from Tripler Army ... Orthopaedic Society for Sports Medicine’s ( AOSSM ) Specialty ... surgery was not performed. , The final study group ... and 17 receiving non-surgical therapy. Of the non-surgery group, ...
(Date:3/28/2015)... 28, 2015 Healthpointe’s otolaryngologists, medical practitioners ... throat disorders, are now offering a wide variety ... which is characterized by the presence of phantom sounds ... people, tinnitus is a prevalent symptom that can arise ... is non-fatal, tinnitus can impede a person’s quality of ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
(Date:3/27/2015)... FL (PRWEB) March 27, 2015 Florida Hospital ... Storm as the team’s exclusive health care provider for the ... provider, Florida Hospital provides medical care and an athletic trainer ... Storm will kick off its season against the Cleveland Gladiators ... , “This partnership is extremely important to us as it ...
Breaking Medicine News(10 mins):Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 2Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 3
... and then his legs become contorted into a complex yoga ... arch in the shape of the letter "C." , ,Sahakian ... His instructor does the work for him, performing a Thai ... moving, with ironically little work on the client's part. Some ...
... with endometriosis may have an increased risk of developing ... brain cancer. ,Endometriosis is a condition where tissue lining ... areas. The misplaced tissue may be found on the ... uterus.// Endometriosis is the most common cause of pelvic ...
... of obstructive sleep apnea, a sleep disorder that causes people ... to also promote bed-wetting in children, said Dr. Lee J. ... of Pennsylvania in Philadelphia. ,In a study of 160 ... sleep-disorders //clinic for suspected breathing problems at night, 66 children ...
... WHO said on Friday it expected to announce the removal of ... regions or countries where new cases of the deadly virus had ... period for the disease is 10 days, and twice that time ... local emergency situation over. ,The move, due to be announced ...
... of their brains than people who speak English, scientists ... insight into how the brain processes language. ,Unlike English ... understand the language, scientists at the Wellcome Trust research ... brain are used to interpret variations in sounds in ...
... That traffic ticket you just received could be preventing a ... say researchers who studied the impact of traffic convictions on ... ,Results show drivers run a significantly lower risk of getting ... conviction when compared to other months when no conviction took ...
Cached Medicine News:Health News:The 'lazy man's yoga" 2Health News:Sleep Apnea Linked to Bed-Wetting in Kids 2Health News:SARS-Free Taiwan to Mark End Phase of Global Fight 2
... immunosorbent assay method for the semi-quantitative determination ... human serum. The results of the anti-Gliadin ... aid in the diagnosis of diseases associated ... Coeliac Disease. Levels of these autoantibodies are ...
... a high throughput primary or backup ... offers performance and reliability equal to ... instruments. The advanced technology of the ... strips delivers reproducible and accurate results, ...
... assay was originally developed for the World ... ovarian function. It has been widely used ... of natural family planning methods. Urine samples ... concentration measured by EIA (enzyme labelled immunoassay ...
... 10-8700 ACTIVE® Estrone Enzyme Immunosorbent Assay ... quantitative measurement of Estrone in serum. ... of enzyme immunoassay where there is ... an enzyme-labeled antigen for a fixed ...
Medicine Products: